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Abstract
Background
Severe acute malnutrition (SAM) is a major global health problem affecting some 16.9 mil-
lion children under five. Little is known about what happens to children 6–24 months post-
discharge as this window often falls through the gap between studies on SFPs and those
focusing on longer-term effects.
Methods
A protocol was registered on PROSPERO (PROSPERO 2017:CRD42017065650).
Embase, Global Health and MEDLINE In-Process and Non-Indexed Citations were system-
atically searched with terms related to SAM, nutritional intervention and follow-up between
June and August 2017. Studies were selected if they included children who experienced an
episode of SAM, received a therapeutic feeding intervention, were discharged as cured and
presented any outcome from follow-up between 6–24 months later.
Results
3,691 articles were retrieved from the search, 55 full-texts were screened and seven met
the inclusion criteria. Loss-to-follow-up, mortality, relapse, morbidity and anthropometry
were outcomes reported. Between 0.0% and 45.1% of cohorts were lost-to-follow-up. Of
those discharged as nutritionally cured, mortality ranged from 0.06% to 10.4% at an average
of 12 months post-discharge. Relapse was inconsistently defined, measured, and reported,
ranging from 0% to 6.3%. Two studies reported improved weight-for-height z-scores, whilst
three studies that reported height-for-age z-scores found either limited or no improvement.
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Conclusions
Overall, there is a scarcity of studies that follow-up children 6–24 months post-discharge
from SAM treatment. Limited data that exists suggest that children may exhibit sustained
vulnerability even after achieving nutritional cure, including heightened mortality and morbid-
ity risk and persistent stunting. Prospective cohort studies assessing a wider range of out-
comes in children post-SAM treatment are a priority, as are intervention studies exploring
how to improve post-SAM outcomes and identify high-risk children.
Introduction
Severe acute malnutrition (SAM) is a major public health problem, estimated to affect 16.9
million children under 5 across the globe in 2017, causing over 516,000 child deaths per year
[1, 2]. Estimating numbers of cases of SAM are obtained from prevalence surveys with an inci-
dence correction factor applied. Calculating incidence using longitudinal data would provide a
more accurate estimate of the caseload of SAM and mortality attributable to it. However, this
type of data is rarely collected and therefore these figures likely underestimate the real burden
of SAM [3]. The World Health Organisation’s (WHO) case definition of SAM specifies the
presence of at least one of these three independent criteria: <-3 z-scores weight-for-height
(WHZ), mid-upper arm circumference (MUAC) of<115mm, and presence of bilateral pitting
oedema (also known as ‘kwashiorkor’) [4].
Current WHO management protocols are public-health focused and include: an emphasis
on high programme coverage; early identification of affected children, allowing those with an
appetite and who are clinically stable (i.e. ‘uncomplicated’ SAM) to be managed as outpatients
using Ready-to-Use Therapeutic Food (RUTF); and inpatient care for the much smaller num-
ber of children with additional medical complications [5, 6]. This ‘Community-Management
of Acute Malnutrition’ (CMAM) model of care is cost-effective, allows for increased caseloads,
and is now supported by substantial evidence of having contributed to lower mortality rates
from SAM [6–9].
Whilst there are currently no universal performance targets for CMAM programmes, the
minimum standards set by the SPHERE humanitarian charter are globally recognised and
widely used as basic targets for mortality, defaulter and recovery rates [10]. These are all short-
term outcomes and contribute to many CMAM evaluations focusing on short-term successes
only. Longer-term outcomes also matter and, if different to short-term outcomes, may indicate
the need for additional care after the initial treatment episode. The wider perspective of
CMAM outcomes is often neglected, despite evidence of high post-treatment mortality
highlighted by a literature review in 2012 [11].
The WHO protocol for the management of SAM states that after discharge from treatment
programmes children should be periodically monitored to avoid relapse, but has no clear defi-
nition of relapse nor does it provide specific guidance on how often and by whom this should
be performed [6]. In some settings, successful rehabilitation from SAM is followed by referral
for a further period of nutritional support in a supplementary feeding programme (SFP). Since
SFPs are primarily for the treatment of moderate acute malnutrition (MAM) and are often run
by different organisations to those running the CMAM programme, this can involve several
challenges. SFPs are not universally available, data linkages are often weak so it may not be
possible to know whether a child attended and how he/she fared on SFP, and SFP management
protocols have a weaker evidence base than those for SAM [12–15].
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A post-SAM follow-up period of 6–24 months is particularly neglected as the current evi-
dence base tends to focus on short-term outcomes (<3 months after treatment for SAM) and
longer-term outcomes (>24 months after treatment). Studies focusing on shorter-term out-
comes document high levels of mortality and deterioration to MAM and low rates of sustained
recovery [16–19]. Studies exploring longer-term outcomes in older children find evidence for
increased stunting, reduced lean muscle mass, weaker hand grip and changes in electroen-
cephalogram activity [20–22].
To date, there is no systematic review of outcomes at follow-up between 6–24 months after
discharge from treatment for SAM in the literature. We aimed to identify and synthesise the
current evidence on the outcomes of children who have been followed-up 6–24 months post-
discharge from treatment for SAM using a systematic search strategy. Through highlighting
our current knowledge and current evidence gaps in this area we hope to inform future pro-
grammes, research, and policy in order to improve sustained recovery and help children not
only survive, but thrive after an episode of SAM.
Methods
Search strategy
Our protocol was registered on PROSPERO (PROSPERO 2017:CRD42017065650) on 11th
May 2017 (S1 File). We conducted a systematic literature search in Global Health, Embase
and MEDLINE In-Process and Non-indexed citations databases between June and July 2017
with the last search on 19th July. However, search alerts were turned on and new articles
screened for eligibility until 28th August, Search strategy was formulated using search terms
and subject headings for 1) severe acute malnutrition, 2) child/infant, 3) therapeutic feeding
intervention, 4) synonyms for the outcome parameter “follow-up”; using Medical Subject
Headings and free text terms. No date limits were applied. Detailed information on the combi-
nations of search terms used in our search strategy is shown in S2 File.
Study selection
Inclusion criteria were studies in which children aged 6–59 months in a Low- or Middle-
Income Country experienced an episode of SAM, received an inpatient or outpatient thera-
peutic feeding intervention for the treatment of SAM, were subsequently discharged as cured,
and who presented any clearly defined outcome between 6 and 24 months of follow-up after
discharge. Definitions of SAM included in this review were<-3 WHZ or <70% weight-for-
height (WFH) using the 1977 National Centre of Health Statistics (NCHS) reference median
or the 2006 WHO Growth Standards, MUAC< 115mm, MUAC <110mm, bipedal-oedema
or clinical diagnosis of marasmus, kwashiorkor or marasmic-kwashiorkor [23, 24]. Discharge
criteria for cured was as per study definition.
Exclusion criteria were unpublished studies or grey literature, reviews, non-human studies,
studies focusing on management of SAM in infants <6 months, studies in high-income coun-
tries and studies not published in English language or published in abstract form only.
Screening process
Titles and abstracts were screened against a screening form by the lead author only. The full text
was then evaluated for complete suitability and included in review if it qualified. Data extraction
forms were piloted then used on all studies to collect information on study details and out-
comes. The standardized data extraction form is available in S3 File. Risk of bias was assessed at
the study level using ‘Methods for the development of NICE public health guidance’ [25, 26].
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Due to the heterogeneous nature of study designs, participants and outcomes, it was not
meaningful to synthesize the results in a meta-analysis. The PRISMA (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses) guideline was followed, except for the items
relating to meta-analysis (S1 Checklist).
Results
We screened 3,691 records, ultimately identifying seven eligible articles following full-text
review and searching of reference lists (Fig 1) [27–33]. Table 1 presents a summary of included
studies’ results. The most common reason for exclusion (23 studies) was not meeting the case
definition of SAM. A table of some of these excluded studies with the most similar admission
criterion to our specification is available in S1 Table. Fifteen studies were excluded as out-
comes reported did not fall into our pre-defined period of 6 to 24 months. Three of the studies
took place in India, two in Malawi and one each in Burkina Faso and Bangladesh. All seven
had different admission criteria and four of them had different discharge criteria. The quality
assessment of the studies is available in S2 Table.
Loss-to-follow-up
Loss-to-follow-up ranged from 0.0% to 45.1%. Aprameya et al. identified that distance from
nutritional rehabilitation unit (NRU), travelling and food expenses, and loss of daily wages
reduced compliance with follow-up visits [28]. Two studies found differences in baseline char-
acteristics of children lost-to-follow-up. Losses and intermittent follow-up were more com-
mon in children who had been inpatients (p = 0.003) in Khanum et al. [33], and children lost-
to-follow-up were more likely to be admitted with a smaller MUAC in Somasse et al. [32].
Mortality
Mortality was calculated solely for the period of 6–24 months after discharge from therapeutic
feeding programmes, despite many studies reporting a combined total of in-programme and
after-discharge mortality. The highest number of post-discharge deaths reported was 10.4%
(49/471) in Kerac et al [27]. The lowest mortality reported was 0.6% (10/1659) by Burza et al.
[29]; but when we consider only those who were traced successfully, this increases to 7.9% (10/
1264), similar to the 8.5% (7/82) seen in Somasse et al. [32].
Post-discharge mortality of treatment programmes in Asia was generally lower compared
to those operating in Africa. CMAM programmes reported lower mortality compared to inpa-
tient programmes operating in the same continent. However, the number of studies is too
small to decipher if this is significant.
Relapse
There were multiple discrepancies between the studies’ definition of relapse, and the timing of
its measurement. Some studies reported relapse as a point prevalence, based on a single data
collection point, whilst others reported incidence based on multiple data collection points. In
Khanum et al., 0.6% (3/437) re-met the admission criteria at 1-year post-discharge. In Khare
et al. 6.3% (2/32) had re-experienced SAM during the 15 months, but none of the children
were experiencing it at the time of follow-up. In Aprameya et al. children were defined as
recovered (defined as WHZ1), or not recovered (WHZ-3 but<-1) at 6 months. 24.1%
(22/91) were classified as not recovered, and there were more children in this group who had
SAM due to an underlying systemic illness than from poor nutrition (p = 0.023) [28]. 41.7%
(38/91) of the children were defined as having recovered. At a single measurement 15 months
Follow-up after severe acute malnutrition
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Fig 1. PRIMSA flow diagram.
https://doi.org/10.1371/journal.pone.0202053.g001
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Table 1. Summary of results of studies included in review.
Title, Author,
Year, Study Design
Population & Setting Number
discharged
as cured
Admission (A) &
Discharge (D) Criteria
Description of
intervention
Description and
timing (Months,
mo) of Follow-Up
Outcomes reported &
findings in children
discharged as cured
Management of
Kwashiorkor in its Milieu-
A follow-up for Fifteen
Months
All Under-5s
(n = 1799) in 20
villages surveyed.
32 A: Clinical diagnosis of
kwashiorkor
Outpatient Monthly weight,
height and diet
recorded for
15mo.
Loss-to-follow-up: 0/32
(0%)
Khare, RD et al. [31] Undertaken at the
Rural Health Unit at
a hospital in
Mumbai, India
D: Oedema resolved
and weight 65% of local
growth chart reference
levels
Local foods Outcomes
presented at
15mo
Mortality: 2/32 (6%)
1976 Relapse: 2/32 (6%)
Prospective cohort study Morbidity: 25/32 (78%)
helminthiasis 16/32 (50%)
signs of Vitamin A
Deficiency 14/32 (44%)
infection of some kind 12/
32 (38%) tichuriasis 2/32
(6%) tuberculosis 32/32
(100%) anaemic
Growth, morbidity, and
mortality of children in
Dhaka after treatment for
severe malnutrition: a
prospective study
12–59 months 437 A1: <60% weight-for-
height (WFH) (NCHS)
Children had
previously been
enrolled in a
randomised trial
with three arms:
inpatient, day-care or
domiciliary-care
Visited at home
every two weeks
for 12mo.
Loss-to-follow-up: 102/437
(23%) 33/102 (33%) lost
with no trace 4/102 (4%)
excluded due to
tuberculosis 47/102 (46%)
excluded as incomplete
follow-up (<18 visits)
Khanum, S et al. [33] All children admitted
to nutrition
rehabilitation unit
(NRU) between
December 1990 and
November 1991
Dhaka, Bangladesh
A2: Bipedal oedema Milk-based feeds and
salt-free meals
Outcomes
presented at
12mo.
Mortality: 10/437 (2%) 8/
10 (80%) female
1998 D:80% WFH median
(NCHS growth
references)
Relapse: 3/437 (0.6%)
Controlled trial Readmissions due to
medical emergency: 5/437
(1%)
Morbidity: Illness recorded
in 35% fieldworkers’
fortnightly visits. 308/335
(92%) experienced
diarrhoea over the 12mo.
Mean episodes: 7 (range:
0–30). 322/335 (96%)
experienced cough with
fever
Anthropometry (change
from discharge to end of
follow-up at 12 mo.):
Weight-for-height z-score
(WHZ)! from -1.6 to -0.9
Weight-for-age z-score
(WAZ)! from -3.7 to -3.1
Height-for-age z-score
(HAZ)!no change overall,
remained at -4.1
(Continued)
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Table 1. (Continued)
Title, Author,
Year, Study Design
Population & Setting Number
discharged
as cured
Admission (A) &
Discharge (D) Criteria
Description of
intervention
Description and
timing (Months,
mo) of Follow-Up
Outcomes reported &
findings in children
discharged as cured
Uptake of HIV testing and
outcomes within a
community-based
therapeutic care (CTC)
programme to treat severe
malnutrition in Malawi: a
descriptive study
Average age at
admission = 30
months (SD 17.2)
1783 A1: Bipedal-oedema Inpatient/Outpatient
CMAM
Children
previously
discharged from
CMAM invited to
participate.
Loss-to-follow-up: 441/
1783 (25%) 180/1783 (10%)
moved 113/1783 (6%)
wrong address 148/1783
(8%) did not attend
Bahwere, P et al. [30] All under-5s who
had received CMAM
living in the
catchment area of 17
health centres in
Dowa, Malawi
A2: MUAC<110mm Weekly take-home
Ready-to-use-
therapeutic-food
(RUTF)
Outcomes
presented at
median 15.6mo
after discharge.
Mortality: 69/1783 (3.87%)
8/69 (12%) malaria 7/69
(10%) HIV 7/69 (10%)
malnutrition 3/69 (4%)
pneumonia
2008 A3: Marasmus Relapse = 26/1783 (2%)
Retrospective cohort study A4: Other criteria e.g.
twins
D: >80% WFH (NCHS)
+no bilateral-oedema
Follow-up of post-discharge
growth and mortality after
treatment for severe acute
malnutrition (FuSAM
Study): a prospective cohort
study
6–59 months 471 A1: WFH<70% NCHS All initial
stabilization as
inpatient (~3 weeks),
then transferred to
outpatient
therapeutic
programme (OTP)
(~10 weeks)
Ward-based
review on 1-year
anniversary of
discharge date
from OTP or
followed-up at
home >12mo
post-discharge.
Loss-to-follow-up: 57/471
(12%)
Kerac, M et al. [27] 1024 children
admitted to NRU in
Blantyre, Malawi
between July 2006
and March 2007.
A2: MUAC<110mm F75 during
stabilisation, RUTF
in OTP.
Outcomes
presented at
1-year follow-up.
Mortality: 49/471 (10%)
2014 A3: Bipedal oedema Matched with one
or more sibling
controls
identified at
follow-up
Relapse: 7/471 (2%)
Cohort with matched
controls
D: >80% WFH
(NCHS), no oedema,
clinically stable on 2
consecutive visits
Anthropometry (change
from discharge to 12
months): WHZ!1.92 (95%
CI 1.76,2.08) improvement
to 0.04 (SD 1.0).
Comparable to sibling
controls WAZ! 1.66
(1.50,1.82) improvement to
-1.77 (1.1). Mean difference
vs. siblings: -0.55 (-0.71,
-0.3; p<0.01) HAZ! 0.37
(0.21, 0.53) improvement
to -2.97 (1.3) (p<0.01).
Mean difference vs.
siblings: -1.13 (-1.34, -0.93;
p<0.01)
(Continued)
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Table 1. (Continued)
Title, Author,
Year, Study Design
Population & Setting Number
discharged
as cured
Admission (A) &
Discharge (D) Criteria
Description of
intervention
Description and
timing (Months,
mo) of Follow-Up
Outcomes reported &
findings in children
discharged as cured
Socioepidemiological
determinants of severe acute
malnutrition and
effectiveness of nutritional
rehabilitation centre in its
management
6–59 months 91 A1: WHZ <-3 (WHO
Growth Standards) A2:
Bipedal-oedema A3:
MUAC <115mm
Inpatient Called for follow-
up 1, 2, 3 and
6mo after-
discharge
Loss-to-follow-up: 27/91
(30%)
Aprameya, HS et al. [28] Admitted to NRU
between May 2013
and May 2014 in
Mangalore, India.
D1: 5g/kg/day weight
gain for 3 consecutive
days D2: Active &alert
D3: Absence bilateral-
oedema, fever or
infection D4: Tolerating
home-based feeds D5:
Caretaker confident to
take child home
F75 for initial 2 days
then F-100 with rice/
lentils/porridge+ 1
egg/day
Outcomes
presented at 6mo
Mortality: 4/91 (4%) 1/4
(25%) ventricular septal
defect 1/4 (25%)
bronchopneumonia 2/4
(50%) cerebral palsy
2015 Admissions referred
by rural health
workers or identified
at outpatient
department
Discharged at day 14 Recovered (WHZ-1) =
38/91 (42%)
Prospective cohort study Group 1 = SAM
purely due to dietary
deficiency Group
2 = SAM secondary
to chronic infections
or underlying
systemic infections
Not recovered (WHZ <-1
and-3) = 22/91 (24%) 7/
22 (32%) Group 1 15/22
(68%) Group 2 Difference:
p = 0.023
Relapse = 0/91 (0.0%)
Morbidity = 39/91 (43%)
experienced recurrent
respiratory illness 14/91
(15%) experienced
recurrent diarrhoeal illness
Weight gain (Mean weight
(kg) at discharge and 6mo)
= Group 1 9.4 (2.0 SD)!
10.3 (2.2) Group 2 8.1 (2.4)
! 8.9 (2.6) Difference:
p<0.001
Seasonal effect and long-
term nutritional status
following exit from a
community-based
management of severe acute
malnutrition program in
Bihar, India
6–59 months 1659 A1: MUAC <115mm Inpatient/Outpatient
CMAM
Children
discharged 3, 6, 9,
12 or 18mo
previously were
traced (different
cohorts)
Loss-to-follow-up: 395/
1659 (24%)
Burza,S et al. [29] 2667 children
received CMAM
between February
2009 and September
2011 in Bihar, India
A2: Bipedal oedema RUTF Outcomes
presented for
these periods
combined
Mortality: 10/1659 (1%)
2016 D: MUAC >120mm, no
oedema for 1 week
+ clinically well and
good appetite for 2
consecutive visits
Relapse into SAM: 45/1659
(2.7%)
(Continued)
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after discharge in Bahwere et al. 26/1783 (1.5%) were malnourished (WFH<80% reference
median and/or bilateral pitting oedema). Although not included in their definition of relapse,
one additional child had a MUAC <110mm, and five had MUAC <125mm. There were stark
differences in relapse rates according to HIV serostatus; 14.3% (4/28) in HIV+ compared to
2.0% (22/1094) in HIV-, in those children with known outcomes. 2.7% (45/1659) of all chil-
dren discharged as cured met the criteria for SAM admission (MUAC<115mm and/or bipedal
oedema) at a single measurement either 3, 6, 9, 12, or 18 months (average 9 months) post-dis-
charge in Burza et al. [29]. As was done with mortality, when it is calculated for only children
with known outcomes this increases to 3.6% (45/1264). When also including the case defini-
tion for MAM, 27.5% (347/1264) relapsed to SAM or MAM at an average follow-up time of 9
months.
Morbidity
In Aprameya et al. 42.9% (39/91) and 15% (14/91) of children post-discharge had recurrent
respiratory or diarrhoea illnesses during follow-up (28). 43.8% (14/32) in Khare et al. had
some form of infection, 100% (32/32) were anaemic and 78.1% (25/32) had helminthiasis [31].
402/437 (92%) in Khanum et al. experienced at least one episode of diarrhoea over the course
of the 12-month follow-up, but the mean was seven episodes (range = 0–30) [33]. 292/437
(67%) attended an outpatient health centre with diarrhoea (105/437 (24%) at least three
times), 319/437 (73%) with fever (114/437 (26%) at least three times) and 254/437 (58%) with
pneumonia (44/437 (10%) at least three times). 420/437 (96%) reported a cough with fever;
although this was less frequent in the domiciliary care group (p = 0.03). However, the domicili-
ary care group had an older age at admission (29 months vs. 25 and 26 months for inpatient
and day-care groups, respectively) which could be a factor in this.
Table 1. (Continued)
Title, Author,
Year, Study Design
Population & Setting Number
discharged
as cured
Admission (A) &
Discharge (D) Criteria
Description of
intervention
Description and
timing (Months,
mo) of Follow-Up
Outcomes reported &
findings in children
discharged as cured
Retrospective cohort study Number with moderate
acute malnutrition: 302/
1659 (18%)
Anthropometry (from
discharge to 12m follow-
up): HAZ! improved by
0.7 (0.5,0.9, p<0.001)
Relapses from acute
malnutrition and related
factors in a community-
based management
programme in Burkina Faso
6–59 months 82 A1: MUAC<110mm Outpatient CMAM
(uncomplicated SAM
only)
Children
discharged from
CMAM 6-20mo
previously
identified
Loss-to-follow-up: 37/82
(45%)
Somasse,YE e al. [32] Children received
CMAM for SAM and
MAM between July
2010 and June 2011
in Burkina Faso
A2: Bipedal oedema Weekly take-home
RUTF
Mortality: 7/82 (9%)
2016 Identified via one-
stage stratified and
clustered sampling
D: WHZ >-2 z-scores
(WHO Growth
Standards) & no
oedema
Retrospective cohort study
https://doi.org/10.1371/journal.pone.0202053.t001
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Anthropometry
Kerac et al. found that from discharge to 12-months children underwent large catch-up in
WHZ [27]. A mean improvement in WHZ of 1.92 (95% CI: 1.76, 2.08) brought them to a
mean value of 0.04 WHZ at 12 months post-discharge; comparable to sibling controls and the
global norm. WAZ also improved by 1.66 (1.50, 1.82) giving a mean value of -1.77. However,
this was below that of sibling controls by -0.55 WAZ (-0.71, -0.38; p<0.01). This could be
explained by HAZ, as there was only a small mean improvement of 0.37 (0.21, 0.53, p<0.01) to
reach a final value of -2.97 (1.3 SD), below that of the sibling controls by -1.13 (-1.34, -0.93;
p<0.01). Burza et al. noted similarly small levels of improvement in HAZ: a 0.7 (0.5, 0.9,
p<0.001) increase from discharge to 12-months [29].
Khanum et al. also observed increases in mean WHZ and WAZ from discharge to
12-months of -1.6 to -0.9 and -3.70 to -3.08, respectively [33]. Mean HAZ did not improve
over follow-up and remained at -4.14; classified as severe stunting. No associations were found
between time with diarrhoea, fever or cough and levels of weight or height gain.
In Aprameya et al. there was an increase in mean weight from 9.2kg (2.0 SD) at discharge
to 10.3kg (2.2) at 12-months for children without underlying illness (p<0.001) [28]. The same
increase was observed for children with underlying illnesses from 8.1kg (2.4) to 8.9kg (2.6)
(p<0.001), albeit lower at each time point. The difference in weight gain between groups was
also significant (p<0.001).
Discussion
Our systematic search of the literature on post-SAM treatment outcomes highlighted that
there is very limited data reporting what happens to children after successful initial cure. In
the existing studies there is marked diversity in the study design, population, HIV prevalence,
admission and discharge criteria, nutritional intervention provided and definition of relapse,
which make it challenging to directly compare studies. Despite the great variability between
different studies and settings, our results suggest that despite nutritional recovery, some
affected children remain vulnerable 6–24 months later, manifested through a variety of
outcomes.
Mortality
Routine SAM programme monitoring would have missed the post-discharge mortality that we
observed. It is important to consider that the mortality reported here was calculated solely for
the period of 6–24 months post-discharge (depending on the length of study follow-up) fol-
lowing nutritional cure, and does not include in-programme mortality. Mortality even among
this group of “healthy survivors” is thus striking and is likely to reflect the fact that some chil-
dren who present with SAM have pre-existing vulnerabilities, whereby SAM is manifested as a
symptom and/or sign of those vulnerabilities, rather than due to poor dietary quality and/or
quantity alone. Therapeutic feeding is thus sometime analogous to treating infection-related
fever: an important part of the “package” of care but not necessarily addressing the root issue.
Aside from infection (which is already treated in existing therapeutic feeding programmes)
many other possible causes of poor growth are recognised which can be difficult to identify
and address even in resource-rich settings, for example biological causes such as malabsorp-
tion, metabolic disorders and disability, and social causes such as neglect (either deliberate or,
more often, due to complex family circumstances such as illness and poverty) [34, 35].
The highest post-treatment mortality reported by Kerac et al. of 10.4% is above even the in-
programme SPHERE standards of<10% mortality [27]. This reflects the initial high-risk
cohort: children were all originally admitted to inpatient care in 2006–2007, when CMAM
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services were unavailable locally and hence cases tended towards the ‘complicated’ end of the
SAM spectrum. Malawi also has a high background child mortality as well as a high prevalence
of HIV (43.5% (445/1024) of the original cohort of admissions were HIV seropositive) [36].
Another study in Malawi which followed-up children for four months after discharge found
that HIV seropositive children were nearly three times more likely to die during nutritional
rehabilitation; a 35.4% mortality risk compared to 10.4% (p<0.001) [37].
Relapse
The current lack of a standard definition for post-discharge relapse was evident in these stud-
ies. The inconsistency in the definition and measurement of relapse means it is largely not pos-
sible to compare differences in, and burden of relapse across the different contexts. Although
relapse reported in studies included in this review range from 0% to 6%, many other studies
with shorter follow-up periods cite much higher figures. A study in Ethiopia found that 14
weeks after admission into an OTP, 34.6% had relapsed to SAM and a further 37.5% had
MAM [17]. Relapse to SAM was 11.1% measured at monthly follow-up visits over the course
of 6 months in the Democratic Republic of Congo, and this increased to 44.2% when relapse to
MAM is included [38].
Morbidity
High levels of morbidity, in particular diarrhoeal and respiratory illnesses, were reported in all
three studies that measured morbidity [28, 31, 33]. A study in Ethiopia that followed-up chil-
dren six months post-discharge found that there was approximately a 1.7 times higher inci-
dence of fever, diarrhoea and cough in children discharged as cured compared to controls
[39]. The synergistic effect of malnutrition and infection on risk of mortality is well-docu-
mented, and this review furthermore highlights the potential need for additional care for
recovered malnourished children in order to prevent infection, as vulnerability to infection is
still present despite recovery in WHZ [40].
Anthropometry
Both included studies that measured WHZ at 6–24 months showed that children were no lon-
ger wasted [27, 33]. This has been observed by multiple other studies, including a Bangladesh
follow-up that found WHZ increased from -2.5 (0.6 SD) at discharge to -1.9 (1.0) at 6 months
[21, 41, 42]. A study from India that followed-up children between one and three, and five and
seven years after an episode of SAM found that their mean WHZ was higher than their siblings
who had not experienced malnutrition [21]. Whilst it is reassuring that complete or near-com-
plete catch-up in WHZ is possible, there are potentially important life-course implications for
these children as suggested by the accumulation of evidence on the Developmental Origins of
Health and Disease (DOHAD) highlighting associations between rapid weight gain in infancy
and later risk of non-communicable diseases (NCDs) [43].
Overall good recovery of WHZ needs to be seen in context of less impressive changes in
other anthropometric indicators. All three studies included in this review that measured HAZ
found there were, at best, limited improvements, which is consistent with the wider literature
[27, 29, 33, 42, 44–46]. The lack of catch-up in HAZ is a significant concern and of critical
importance as severely stunted children are 5.5 times more likely to die, and furthermore are
12.3 times more likely to die when any degree of stunting and wasting occur concurrently [47,
48]. Long term adverse health associated with stunting has been well described and includes
an increased risk of suboptimal cognitive and physical development and risk of adult NCDs
[49]. A recent Technical Briefing Paper on the relationship between wasting and stunting has
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helped the international community begin to recognise the gap in both knowledge and pro-
gramming between these two forms of malnutrition, but this remains a problem to be
addressed [50].
Limitations
The use of different admission criteria (WHO versus NCHS; WHZ versus MUAC), which do
not overlap perfectly, identifying similar but not the same children, has likely resulted in the
subsequent study populations having variable initial risks of mortality and morbidity [51–53].
This issue was compounded by the use of different discharge criteria which resulted in distinct
groups of children classified as recovered, making it hard to differentiate between post-dis-
charge mortality and morbidity in recovered children and those who never achieved nutri-
tional rehabilitation (had they been in a different programme).
Relatively high losses to follow-up also limit what can be learnt from our review. Of chil-
dren not found at 6–24 months post-treatment, some will have died, some will be alive but
unwell or still malnourished, and some will be alive and well [54]. What percentage are in each
category is likely to vary programme to programme, but what is almost certain is that known
mortality and morbidity are underestimates of the true value.
There is a significant risk of bias across all the studies in the review. Firstly, survivor bias
will have likely affected all the studies and is critical to their interpretation. Only the healthiest
children of those originally admitted for SAM would have made it to nutritional cure in the
first place. It is therefore particularly striking that some of these are still at risk of mortality and
morbidity over six months post-nutritional cure.
Kerac et al. was the only study which employed a control group to assess relative risk of
observed outcomes: siblings living in the same household [27]. However, although 90% of sib-
lings had never experienced SAM, they may have exhibited a degree of undernourishment
themselves, which could reduce the effect size. In addition, HIV status was not known or
reported on in all studies; despite being an important risk factor for poor outcomes in African
studies [55]. In the absence of control groups in all studies except for Kerac et al., we cannot
estimate the relative risk of our outcomes and the attributable risk of these related to a previous
SAM episode. Despite being unable to say whether there is an excess of e.g. mortality and
stunting among children after an episode of SAM, we feel the observed high rates give some
cause for concern.
We must also be aware of other variables that influence the extent to which the study results
are generalisable. For example, the infectious disease burden, health facility coverage, and food
security status of a local population are factors that may influence the outcomes considered in
this review, and therefore necessitate context-specific interpretation. Such factors need to be
measured and analysed in future studies to better assess the associations between being treated
for SAM and the observed outcomes in these cohort studies.
The final constraint when it comes to critical appraisal of the studies in this review is the
lack of targets or standard literature to assess whether and to what extent observed mortality
and morbidity represents an excess over that in the general population. All settings in which
SAM is a public health problem are by definition high-risk. Without more background infor-
mation on reference population mortality and morbidity, it is hard to quantify the excess risks
in our post-SAM children. More context-specific information would be helpful to assess the
additional level of support required for SAM survivors.
There are several methodological limitations of the review which warrant mention.
Restricting to English language, published papers in the search strategy means not all relevant
research may have been identified, and omission of important studies remains a possibility.
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Selection or reviewer bias could also have occurred given studies were not screened or
abstracted in duplicate.
Programmatic recommendations
Our results highlight the urgent requirement of a uniform definition of relapse. Once defined
a simple method to enable programs to assess relapse should be devised, with consideration to
the limited capacity of most programmes to collect data. Providing mothers with MUAC tapes
could facilitate collection of such data. This would be in line with the current field of thinking,
as in 2017 The Council of Research and Technical Advice on Acute Malnutrition (CORTA-
SAM) recommended that MUAC should be used as a primary admission criterion for SAM
programmes [56]. Mobile phones within households or communities could be a useful tool for
reporting relapse and mortality.
In order to ascertain a more complete evaluation of CMAM programmes, mortality and
relapse 6 months post-discharge should be initiated as critical indicators of performance. In
particular, post-treatment relapse rates and causal factors have been identified as a priority
research area by the No Wasted Lives Coalition [57]. Conducting secondary analysis on exist-
ing high-quality programme data could aid the creation of a validated tool for use at discharge
that systematically identifies children at highest risk of mortality and relapse. Routine referral
to post-discharge nutrition-specific and nutrition-sensitive interventions such as the key Lan-
cet evidence-based interventions, could be put in place for the most vulnerable children [58].
Research recommendations
The dearth of literature in this area must be addressed, therefore conducting prospective
cohort studies in a broader range of geographic and endemic disease settings in children post-
SAM should be made a priority, alongside intervention studies exploring how to improve
post-SAM outcomes and identify high-risk children. New studies should aim to provide a
more comprehensive description of the problem, with particular focus on mortality and stunt-
ing. Mortality, stunting and relapse to SAM should be compared with sibling or community
controls, alongside anthropometry, to give a more complete picture of the vulnerability of
post-SAM children, and allow us to assess the attributable risk of these adverse outcomes to a
previous episode of SAM. Furthermore, improved understanding of the risk factors that lead
to relapse and excess mortality is needed. This can be achieved via case-control studies com-
paring relapsed with non-relapsed treated SAM children.
Randomised control trials are needed to determine interventions that can prevent relapse.
One possibility is unconditional cash transfers, which were found to decrease the proportion
of relapse to SAM following treatment in a recent study [38]. Determining whether this
approach works in different settings and prevents relapse in the long-term should be made a
priority. Another approach that needs urgent consideration is whether to treat SAM children
with antibiotics after discharge from treatment. A recently published study suggests that treat-
ment with antibiotics can reduce mortality in children even in the absence of malnutrition in
different settings [59]. Children treated for SAM should be included in intervention studies
that aim to improve HAZ through a variety of methods, including during adolescence [60].
Qualitative data should be collected to investigate and understand the role of the home envi-
ronment and child feeding practices in children who relapse or die.
The increased risk of prevalence of chronic disease in children treated for SAM warrants
further investigation. There is clearly a need to balance the short-term benefits of rapid weight
gain with the possible long-term adverse consequences. Randomised control trials are required
to explore the trade-off between slow and rapid weight gain. If the evidence suggests rapid
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weight gain is problematic, different treatment protocols should be tested with the aim of min-
imising future adverse consequences. A RUTF with a lower sugar content should be trialled in
the light of the growing body of literature suggesting that high sugar foods can predispose to
obesity [61].
As many studies in this review were excluded because they admitted on WAZ (See S3 File),
admission criteria for future studies should be based on WHO definition of SAM, and dis-
charge criteria on the WHO Protocol in order to standardise results. If studies choose to admit
on WHZ, WAZ and HAZ, disaggregated data should be presented according to type of under-
nutrition, alongside age and sex.
As this review suggests, meeting anthropometric criteria for recovery may not equate to
complete recovery and return to baseline risk of mortality and morbidity. The mortality and
morbidity reported in studies suggests that children affected by an episode of SAM take longer
to recover immunologically and physiologically than their weight gain would suggest and
remain susceptible to problems like severe infection even after successful hospital discharge.
Whether this is true for all ex-SAM children of a specific subset is important to determine in
future work. Persisting vulnerability even after apparent nutritional cure may be explained by
SAM being a symptom of other underlying problems (such as disability, malabsorption,
immune dysfunction) rather than a random exposure, and calls for increased understanding
of the aetiology. In order to increase our future understanding of SAM, future studies should
report on a wider range of outcomes alongside mortality and relapse rates, such as body com-
position, cognition, behaviour, educational attainment, metabolism, immunity, and micronu-
trient deficiencies. This may enable us to broaden or re-define our definition of recovery in the
future to one that, for example, could include immune and body composition parameters.
This will allow us to determine when a child has truly returned to healthy physiological state,
and also allows identification and further input to children who remain vulnerable to mortality
and morbidity, despite being deemed recovered based on anthropometric criteria.
Conclusions
Overall, there is a scarcity of studies that follow-up children 6–24 months post-discharge from
SAM treatment. Limited data that exists suggests that children may exhibit sustained vulnera-
bility even after achieving nutritional cure: this includes heightened mortality and morbidity
risk and persistent stunting. Prospective cohort studies assessing a wider range of outcomes in
children post-SAM are a priority as are intervention studies exploring how to improve post-
SAM outcomes and identify high-risk children.
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